{"first_name":"Dennis","last_name":"Purcell","permalink":"dennis-purcell","crunchbase_url":"http://www.crunchbase.com/person/dennis-purcell","homepage_url":null,"birthplace":null,"twitter_username":null,"blog_url":null,"blog_feed_url":null,"affiliation_name":"Unaffiliated","born_year":null,"born_month":null,"born_day":null,"tag_list":null,"alias_list":null,"created_at":"Thu Jun 04 09:47:47 UTC 2009","updated_at":"Thu Jun 04 09:50:24 UTC 2009","overview":"<p>Mr. Purcell has served as the Senior Managing Partner of Fund I and Fund II since February 2000 and is responsible for the management of the Partnership.</p>\n\n<p>Prior to joining Fund I, Mr. Purcell served as Managing Director of the Life Sciences Investment Banking Group at Chase H&amp;Q (formerly Hambrecht &amp; Quist, â€œH&amp;Qâ€) for over five years, and served on the Executive Committee of Hambrecht &amp; Quist. While at Hambrecht &amp; Quist, he was directly involved with over two hundred completed transactions and supervised over $10 billion of financing and advisory assignments in the pharmaceutical, biotechnology, and medical products industries. During his tenure, BioWorld and other industry publications cited H&amp;Q as the leading underwriter of life sciences securities. Mr. Purcell has also often been cited as one of the sectorâ€™s leaders. He was honored in the â€œBiotech Hall of Fameâ€ by Genetic Engineering News and named to the Biotechnology All-Stars list by Forbes ASAP. Prior to joining H&amp;Q, Mr. Purcell was a Managing Director in the Healthcare Group at PaineWebber, Inc.</p>\n\n<p>Mr. Purcell currently serves as a director of Dynova Laboratories, Inc. and Xanodyne Pharmaceuticals, Inc. Previously he served as a director of Aton Pharmaceuticals, Inc., Auxilium Pharmaceuticals, Inc., Cengent Therapeutics, Inc., and Valentis, Inc. He is also a member of the Board of Directors of the Biotechnology Industry Organization (BIO) â€“ Emerging Companies Section. He has served as a member of the Advisory Council at Harvard Medical School. </p>","image":{"available_sizes":[[[95,144],"assets/images/resized/0004/6629/46629v1-max-150x150.jpg"],[[95,144],"assets/images/resized/0004/6629/46629v1-max-250x250.jpg"],[[95,144],"assets/images/resized/0004/6629/46629v1-max-450x450.jpg"]],"attribution":""},"degrees":[{"degree_type":"MBA","subject":"","institution":"Harvard University","graduated_year":null,"graduated_month":null,"graduated_day":null}],"relationships":[{"is_past":false,"title":"Senior Managing Partner ","firm":{"name":"Aisling Capital","permalink":"aisling-capital","type_of_entity":"financial_org","image":{"available_sizes":[[[150,56],"assets/images/resized/0004/6625/46625v1-max-150x150.png"],[[159,60],"assets/images/resized/0004/6625/46625v1-max-250x250.png"],[[159,60],"assets/images/resized/0004/6625/46625v1-max-450x450.png"]],"attribution":null}}}],"investments":[],"milestones":[],"video_embeds":[],"external_links":[],"web_presences":[]}